Gene and variations associated with bm1 phenotype, molecular markers, and their use

Disclosed is an isolated nucleic acid molecule comprising a nucleotide sequence encoding a truncated mutant cinnamyl alcohol dehydrogenase 2 protein lacking NADPH-binding and C-terminal catalytic domains, wherein the protein has at least 90% identity to the amino acid sequence of SEQ ID NO:3 or SEQ...

Full description

Saved in:
Bibliographic Details
Main Authors CHEN WEI, ZHENG PEIZHONG, FITZL DENNIS, KUMPATLA SIVA P, GREENE THOMAS W, FRIEDEMANN PETER D, VANOPDORP NATHAN J
Format Patent
LanguageEnglish
Published 26.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed is an isolated nucleic acid molecule comprising a nucleotide sequence encoding a truncated mutant cinnamyl alcohol dehydrogenase 2 protein lacking NADPH-binding and C-terminal catalytic domains, wherein the protein has at least 90% identity to the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:25; wherein the sequences are as disclosed in the specification.
Bibliography:Application Number: NZ20120612808